Published in J Clin Invest on February 01, 2001
Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest (2003) 2.16
Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J Virol (2004) 1.35
New insights into innate immune mechanisms underlying allergenicity. Mucosal Immunol (2009) 1.23
Innate immunity to Aspergillus species. Clin Microbiol Rev (2009) 1.19
Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation. J Allergy Clin Immunol (2008) 1.10
Recent advances in alveolar biology: evolution and function of alveolar proteins. Respir Physiol Neurobiol (2010) 1.08
Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect Immun (2009) 1.04
Intranasal delivery of a truncated recombinant human SP-D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of Aspergillus fumigatus. Clin Exp Immunol (2002) 1.00
A recombinant fragment of human SP-D reduces allergic responses in mice sensitized to house dust mite allergens. Clin Exp Immunol (2003) 0.91
In vivo rescue of alveolar macrophages from SP-A knockout mice with exogenous SP-A nearly restores a wild type intracellular proteome; actin involvement. Proteome Sci (2011) 0.88
Structural characterisation of ligand-binding determinants in human lung surfactant protein D: influence of Asp325. J Mol Biol (2009) 0.87
Surfactant-associated protein A provides critical immunoprotection in neonatal mice. Infect Immun (2007) 0.86
Surfactant protein D-mediated decrease of allergen-induced inflammation is dependent upon CTLA4. J Immunol (2010) 0.86
The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema. Arch Dis Child (2003) 0.86
Surfactant protein D alters allergic lung responses in mice and human subjects. J Allergy Clin Immunol (2008) 0.83
Lung effector memory and activated CD4+ T cells display enhanced proliferation in surfactant protein A-deficient mice during allergen-mediated inflammation. J Immunol (2011) 0.81
Differences in the alveolar macrophage proteome in transgenic mice expressing human SP-A1 and SP-A2. J Proteom Genom Res (2013) 0.80
Allergens/Antigens, toxins and polyketides of important Aspergillus species. Indian J Clin Biochem (2011) 0.80
Surfactant protein-A inhibits Aspergillus fumigatus-induced allergic T-cell responses. Respir Res (2005) 0.80
Effect of irradiation/bone marrow transplantation on alveolar epithelial type II cells is aggravated in surfactant protein D deficient mice. Histochem Cell Biol (2016) 0.80
Review: Collectins link innate and adaptive immunity in allergic airway disease. Innate Immun (2010) 0.79
Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help? Am J Respir Cell Mol Biol (2014) 0.79
Monocyte CD64 or CD89 targeting by surfactant protein D/anti-Fc receptor mediates bacterial uptake. Immunology (2006) 0.78
Genetic variants and monoallelic expression of surfactant protein-D in inflammatory bowel disease. Ann Hum Genet (2011) 0.78
Therapeutic use of surfactant components in allergic asthma. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.78
Surfactant protein D facilitates Cryptococcus neoformans infection. Infect Immun (2012) 0.78
Human surfactant protein D alters oxidative stress and HMGA1 expression to induce p53 apoptotic pathway in eosinophil leukemic cell line. PLoS One (2013) 0.78
Prophylactic and Therapeutic Potential of Asp f1 Epitopes in Naïve and Sensitized BALB/c Mice. Immune Netw (2009) 0.76
Effects of surfactant protein-A on the interaction of Pneumocystis murina with its host at different stages of the infection in mice. J Eukaryot Microbiol (2009) 0.76
Crystal Structure of a Complex of Surfactant Protein D (SP-D) and Haemophilus influenzae Lipopolysaccharide Reveals Shielding of Core Structures in SP-D-Resistant Strains. Infect Immun (2016) 0.76
Host pathogen interactions in allergic and invasive fungal diseases: Diagnostic and therapeutic implications. Indian J Clin Biochem (2001) 0.75
Comparative evaluation of heterologous production systems for recombinant pulmonary surfactant protein D. Front Immunol (2014) 0.75
Alterations of the murine gut microbiome in allergic airway disease are independent of surfactant protein D. Heliyon (2017) 0.75
Intravenous superoxide dismutase as a protective agent to prevent impairment of lung function induced by high tidal volume ventilation. BMC Pulm Med (2017) 0.75
Allergens with Protease Activity from House Dust Mites. Int J Mol Sci (2017) 0.75
Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization. Front Microbiol (2017) 0.75
Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature (1993) 6.54
Immunomodulatory functions of surfactant. Physiol Rev (1997) 2.48
Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A (2000) 2.32
Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol (1997) 2.18
Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun (1997) 1.97
Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol Rev (1995) 1.69
Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J Exp Med (1996) 1.61
Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol (1999) 1.57
Collectins--soluble proteins containing collagenous regions and lectin domains--and their roles in innate immunity. Protein Sci (1994) 1.45
Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J Immunol (1998) 1.42
A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J Immunol (1992) 1.41
Surfactant proteins A (SP-A) and D (SP-D): levels in human amniotic fluid and localization in the fetal membranes. Biochim Biophys Acta (1994) 1.32
A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid. J Immunol Methods (1998) 1.24
A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo. Eur J Immunol (1999) 1.16
Particulate Aspergillus fumigatus antigens elicit a TH2 response in BALB/c mice. J Allergy Clin Immunol (1994) 1.15
Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin Exp Immunol (1997) 1.11
Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens. Clin Exp Immunol (1996) 1.11
Surfactant protein A (SP-A) gene targeted mice. Biochim Biophys Acta (1998) 1.09
Interactions of surfactant protein D with pathogens, allergens and phagocytes. Biochim Biophys Acta (1998) 1.08
Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. Am J Respir Crit Care Med (1998) 1.04
Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production. Am J Respir Cell Mol Biol (1996) 1.02
Pollen grains bind to lung alveolar type II cells (A549) via lung surfactant protein A (SP-A). Biosci Rep (1993) 1.01
The alpha-helical neck region of human lung surfactant protein D is essential for the binding of the carbohydrate recognition domains to lipopolysaccharides and phospholipids. Biochem J (1996) 1.00
Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet (1999) 0.96
Aspergillus antigen-induced eosinophil differentiation in a murine model. Infect Immun (1992) 0.89
Aspergillus fumigatus antigen induced eosinophilia in mice is abrogated by anti-IL-5 antibody. J Leukoc Biol (1993) 0.86
Surfactant apoprotein in adult rat lung compartments is increased by dexamethasone. Am J Physiol (1991) 0.86
Rapid synthesis of oligodeoxyribonucleotides VI. Efficient, mechanised synthesis of heptadecadeoxyribonucleotides by an improved solid phase phosphotriester route. Nucleic Acids Res (1981) 11.77
Rapid synthesis of oligodeoxyribonucleotides. IV. Improved solid phase synthesis of oligodeoxyribonucleotides through phosphotriester intermediates. Nucleic Acids Res (1980) 7.01
Long-term efficacy of sildenafil and tachyphylaxis effect. J Urol (2001) 5.43
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci U S A (1989) 5.03
HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell (1990) 4.50
Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria. Ann Intern Med (1969) 4.41
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19
Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera. Biochem J (1972) 4.06
Rapid synthesis of oligodeoxyribonucleotides. VII. Solid phase synthesis of oligodeoxyribonucleotides by a continuous flow phosphotriester method on a kieselguhr-polyamide support. Nucleic Acids Res (1982) 3.95
HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J (1990) 3.92
The proteolytic activation systems of complement. Annu Rev Biochem (1981) 3.85
Changes in trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg Am (1970) 3.68
A second serine protease associated with mannan-binding lectin that activates complement. Nature (1997) 3.64
Obliquity-paced Pliocene West Antarctic ice sheet oscillations. Nature (2009) 3.42
The Intensities of X-Rays of the L Series. Proc Natl Acad Sci U S A (1917) 3.39
Water relations in grassland and desert ecosystems exposed to elevated atmospheric CO2. Oecologia (2004) 3.31
Rapid synthesis of oligodeoxyribonucleotides. V. Further studies in solid phase synthesis of oligodeoxyribonucleotides through phosphotriester intermediates. Nucleic Acids Symp Ser (1980) 2.94
Structure-function relationships of the complement components. Immunol Today (1989) 2.74
Rat brain Thy-1 glycoprotein. The amino acid sequence, disulphide bonds and an unusual hydrophobic region. Biochem J (1981) 2.63
Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent Clq of the first component of human complement. Biochem J (1976) 2.62
Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci U S A (1994) 2.58
Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci U S A (2000) 2.58
Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J Immunol (1990) 2.55
Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks. Thorax (1996) 2.54
A collagen-like amino acid sequence in a polypeptide chain of human C1q (a subcomponent of the first component of complement). Biochem J (1974) 2.53
Intestinal malrotation in adults. Indian J Gastroenterol (1991) 2.47
Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem J (1976) 2.46
Activation of the complement system by antibody-antigen complexes: the classical pathway. Adv Protein Chem (1979) 2.39
Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med (1990) 2.29
Biotransformation of dehydroabietic acid with resting cell suspensions and calcium alginate-immobilized cells of Mortierella isabellina. Appl Environ Microbiol (1985) 2.27
The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.26
A multi-antigen print immunoassay for the development of serological diagnosis of infectious diseases. J Immunol Methods (2000) 2.24
Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J Cell Biol (2000) 2.24
Is adult-onset coeliac disease due to a low-grade lymphoma of intraepithelial T lymphocytes? Lancet (1991) 2.21
Molecular cloning and characterization of the cDNA coding for C4b-binding protein, a regulatory protein of the classical pathway of the human complement system. Biochem J (1985) 2.19
Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs. Proc Natl Acad Sci U S A (1991) 2.19
Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (1987) 2.15
Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J Exp Med (1994) 2.15
Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice. Nat Med (2001) 2.08
A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. Neuropsychopharmacology (2008) 2.07
Hydrogen peroxide fogging in an overcrowded tertiary care referral centre: some practical queries. J Hosp Infect (2005) 2.06
Intracuff pressure comparison between ProSeal(®) and Supreme(®) laryngeal mask airways. Anaesthesia (2013) 2.02
Use of a peripheral nerve stimulator for predicting caudal epidural analgesia. Anaesthesia (2000) 2.02
Uranium concentration in groundwater in Hisar city, India. Int J Occup Environ Med (2014) 1.99
Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun (1997) 1.97
The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum. Biochem J (1981) 1.95
C1q: structure, function, and receptors. Immunopharmacology (2000) 1.89
Structures and functions associated with the group of mammalian lectins containing collagen-like sequences. FEBS Lett (1989) 1.87
An electronically collimated gamma camera for single photon emission computed tomography. Part I: Theoretical considerations and design criteria. Med Phys (1983) 1.86
Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocation. Lancet (1990) 1.86
Quality parameters of mango and potential of non-destructive techniques for their measurement - a review. J Food Sci Technol (2010) 1.85
Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax (2000) 1.85
The biochemistry of complement. Nature (1978) 1.84
Production of selenomethionine-labelled proteins using simplified culture conditions and generally applicable host/vector systems. Appl Microbiol Biotechnol (2001) 1.83
Amino acid sequences around the sites of phosphorylation in the pig heart pyruvate dehydrogenase complex. Biochem J (1979) 1.78
The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement. Biochem J (1977) 1.78
Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J Immunol (1997) 1.76
A double-blind placebo-controlled study on prophylactic use of cisapride on feed intolerance and gastric emptying in preterm neonates. Indian Pediatr (2000) 1.74
Complement fixation by the F(ab')2-fragment of pepsin-treated rabbit antibody. Immunology (1971) 1.74
Price of prostatectomy. Br Med J (1974) 1.74
The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins? Microbiology (1999) 1.73
Salience of visual parts. Cognition (1997) 1.73
Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature (1988) 1.73
The role of feedback in the process of health behavior change. Am J Health Behav (2001) 1.72
Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci U S A (1999) 1.69
Bone-seeking radionuclides: an in vivo study of factors affecting skeletal uptake. Radiology (1974) 1.69
Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69
Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J Biol Chem (1997) 1.68
A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression. J Mol Biol (1994) 1.67
Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur J Clin Invest (2001) 1.66
Massively parallel sequencing of the mouse exome to accurately identify rare, induced mutations: an immediate source for thousands of new mouse models. Open Biol (2012) 1.65
Proteins involved in the activation and control of the two pathways of human complement. Biochem Soc Trans (1983) 1.64
Bilateral rhegmatogenous retinal detachment secondary to retinal dialyses associated with multiple retinal breaks. Eye (Lond) (2004) 1.64
Continuities between psychiatric disorders in adolescents and personality disorders in young adults. Am J Psychiatry (1995) 1.61
Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin. Biochem J (1976) 1.61
APOE distribution in world populations with new data from India and the UK. Ann Hum Biol (2006) 1.59
Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis (1995) 1.59
Age specific incidence rate and pathological spectrum of oral cancer in Allahabad. Indian J Med Sci (2003) 1.59
Serodiagnosis of melioidosis in Singapore by the indirect haemagglutination test. Singapore Med J (1991) 1.59
Chemical warfare agents. Environ Toxicol Pharmacol (2008) 1.58
Evaluation of an indanyl ester of carbenicillin. Antimicrob Agents Chemother (Bethesda) (1970) 1.58
A hydrophobic sequence motif common to N-hydroxylating enzymes. Trends Biochem Sci (1998) 1.57
Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol (1999) 1.57
Genetic diversity in European and Mediterranean faba bean germ plasm revealed by RAPD markers. Theor Appl Genet (1995) 1.55
Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol (2006) 1.54
Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol (1999) 1.53
Uterine artery embolization: the role in obstetrics and gynecology. Clin Imaging (2001) 1.53
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut (2008) 1.53
Impact of education and training on neonatal resuscitation practices in 14 teaching hospitals in India. Ann Trop Paediatr (2001) 1.53
A Study of Frequency-Dependent Selection Observed in the Esterase-6 Locus of DROSOPHILA MELANOGASTER Using a Conditioned Media Method. Genetics (1971) 1.52
Effect of single amino acid changes in the region of the adenylylation site of T4 RNA ligase. Biochemistry (1987) 1.50
Macular hole surgery without prone positioning. Eye (Lond) (2006) 1.50
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. Rheumatology (Oxford) (2008) 1.49
Transitional cell carcinoma of the renal pelvis and ureter. Br J Urol (1989) 1.49
Novel mechanisms of estrogen action in the brain: new players in an old story. Front Neuroendocrinol (1999) 1.48
Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci U S A (1988) 1.47
Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis. Scand J Immunol (1998) 1.47